A compound called glucoraphenin found in radish greens significantly reduced weight gain, liver damage, and gut bacteria problems in mice fed a Western diet, according to research reviewed by Gram. In an 8-week study, mice receiving glucoraphenin with their high-fat diet gained less weight, had lower liver enzyme levels indicating less damage, and maintained healthier gut bacteria diversity compared to mice eating only the Western diet. However, this research was conducted in mice, so human studies are needed to determine if the same benefits apply to people.
A compound found in radish greens called glucoraphenin may help prevent obesity and fatty liver disease caused by Western diets, according to research reviewed by Gram. Scientists gave mice a Western diet with added glucoraphenin for 8 weeks and found the mice gained less weight, had healthier livers, and developed better gut bacteria compared to mice eating only the Western diet. The compound appears to work by changing how the body stores fat and by improving the balance of helpful bacteria in the digestive system. While these results are promising, the research was done in mice, so scientists need to test whether the same benefits work in people.
Key Statistics
A 2026 research article published in NPJ Science of Food found that glucoraphenin, a compound from radish greens, significantly reduced weight gain in mice fed a Western diet over 8 weeks compared to mice eating only the Western diet.
According to research reviewed by Gram, glucoraphenin administration suppressed liver damage markers (ALT and AST enzymes) and reduced the expression of six genes involved in fat production in the liver (FAS, SREBP1, mTOR, SCD1, ACC, and ChREBP) in mice with diet-induced fatty liver disease.
A 2026 mouse study found that glucoraphenin prevented the loss of gut bacteria diversity caused by Western diet consumption and restored beneficial metabolites (inosine and hypoxanthine) produced by healthy gut bacteria.
Research shows that glucoraphenin at a dose of 1 mg per kilogram of body weight administered with a Western diet for 8 weeks reduced adipocyte hypertrophy (fat cell enlargement) and lowered serum leptin levels in mice.
The Quick Take
- What they studied: Whether a natural compound from radish greens can prevent weight gain, fatty liver disease, and unhealthy gut bacteria caused by eating a Western-style diet high in processed foods.
- Who participated: Laboratory mice were fed either a Western-style diet alone or a Western-style diet combined with glucoraphenin (a compound from radish) for 8 weeks. The study did not involve human participants.
- Key finding: Mice that received glucoraphenin with their Western diet gained significantly less weight, had lower liver damage markers, and maintained healthier gut bacteria diversity compared to mice eating only the Western diet.
- What it means for you: Eating radish greens or sprouts might help protect against weight gain and liver damage from unhealthy diets, but human studies are needed to confirm this benefit. This is not yet a proven treatment and should not replace medical advice.
The Research Details
Researchers conducted an animal study using mice to test whether glucoraphenin, a natural compound found in radish greens and sprouts, could protect against the harmful effects of a Western-style diet. Mice were divided into groups: some ate a standard healthy diet, some ate a Western diet (high in fat and processed foods), and some ate a Western diet supplemented with glucoraphenin at a dose of 1 mg per kilogram of body weight. The study lasted 8 weeks, which is a significant portion of a mouse’s lifespan.
Throughout the study, researchers measured multiple health markers including body weight, liver function tests, fat cell size, and the composition of bacteria in the mice’s digestive systems. They also examined liver tissue and fat tissue under microscopes to see how the cells had changed. Blood samples were analyzed to measure hormones and metabolites that indicate metabolic health.
This research approach is important because it allows scientists to study the detailed biological mechanisms of how a food compound affects metabolism and the gut-liver connection in a controlled setting. Animal studies can reveal how compounds work at the cellular level before testing in humans. Understanding these mechanisms helps scientists determine whether human studies are worth pursuing and what dosages might be effective.
This study was published in a peer-reviewed journal (NPJ Science of Food), which means other scientists reviewed the methods and findings before publication. The research measured multiple health markers rather than just one outcome, which strengthens the conclusions. However, the study was conducted only in mice, so results may not directly apply to humans. The specific sample size of mice was not provided in the abstract, which limits our ability to assess statistical power. Animal studies are preliminary evidence and should not be considered proof that the same effects occur in people.
What the Results Show
Mice receiving glucoraphenin with their Western diet showed significant reductions in weight gain compared to mice eating only the Western diet. The compound also reduced the size of fat cells and lowered leptin levels (a hormone that increases with obesity). These changes indicate that glucoraphenin helped prevent the body from storing excess fat.
The compound also protected the liver from damage caused by the Western diet. Mice receiving glucoraphenin had lower levels of liver enzymes (ALT and AST) that indicate liver damage. Additionally, the expression of genes involved in fat production in the liver was significantly reduced, meaning the liver was making less fat and storing less of it.
Perhaps most importantly, glucoraphenin prevented the damage to gut bacteria caused by the Western diet. Mice eating the Western diet alone lost diversity in their gut bacteria (meaning fewer types of beneficial bacteria), but mice receiving glucoraphenin maintained healthy bacterial diversity. The compound also helped restore levels of branched-chain amino acids and beneficial metabolites produced by gut bacteria.
The study found that glucoraphenin affected multiple genes and proteins involved in fat metabolism throughout the body. In fat tissue, the compound changed the expression of genes controlling how fat is made and broken down. In the liver, it suppressed the activity of genes like FAS, SREBP1, mTOR, SCD1, ACC, and ChREBP—all of which are involved in producing and storing fat. These widespread effects suggest that glucoraphenin works through multiple pathways rather than a single mechanism. The restoration of microbiota-derived metabolites (inosine and hypoxanthine) suggests the compound helps beneficial gut bacteria produce protective compounds that support overall health.
This research builds on growing evidence that compounds in cruciferous vegetables (like radish, broccoli, and cabbage) have protective effects against metabolic disease. Previous studies have shown that glucosinolates (the class of compounds that includes glucoraphenin) can influence gut bacteria and reduce inflammation. This study is notable because it demonstrates that glucoraphenin specifically addresses the gut-liver axis—the connection between digestive health and liver function—which is increasingly recognized as important for preventing fatty liver disease. The findings align with the broader understanding that Western diets damage gut bacteria, and that restoring healthy bacteria may prevent obesity and metabolic disease.
This study was conducted entirely in mice, so the results may not directly apply to humans. Mice have different digestive systems, metabolic rates, and lifespans than people. The dose of glucoraphenin used (1 mg per kilogram of body weight) would need to be carefully converted to determine an equivalent human dose, and that dose might not be practical or safe in people. The study did not specify how many mice were used in each group, making it difficult to assess whether the sample size was large enough to draw reliable conclusions. The study lasted only 8 weeks, which is relatively short for studying long-term effects in humans. Additionally, the study did not test whether the benefits persist after stopping glucoraphenin or whether higher or lower doses might be more effective.
The Bottom Line
Based on this preliminary animal research, there is not yet enough evidence to recommend glucoraphenin supplements or radish products as a treatment for obesity or fatty liver disease in humans. However, the findings suggest that eating more cruciferous vegetables like radish greens, broccoli, and cabbage as part of a healthy diet may support metabolic health and gut bacteria balance. These vegetables are nutritious and safe to eat in normal food amounts. Anyone with obesity or liver disease should work with their healthcare provider on proven treatments rather than relying on this single compound.
This research is most relevant to people interested in how food compounds affect metabolism and gut health, and to researchers studying obesity and fatty liver disease. It may eventually be relevant to people with metabolic syndrome, obesity, or fatty liver disease, but only after human studies confirm the benefits. People currently taking medications for liver disease or metabolic conditions should not change their treatment based on this animal study. Healthcare providers studying preventive nutrition may find this research interesting as a direction for future human studies.
If glucoraphenin were proven effective in humans, benefits would likely take weeks to months to appear, similar to other dietary interventions. This study showed changes in mice over 8 weeks. However, human studies would need to be conducted first to determine realistic timelines for people. Do not expect immediate results from any dietary change.
Frequently Asked Questions
Can I eat radish to prevent obesity and fatty liver disease?
Radish contains glucoraphenin, a compound that showed promise in mice, but human studies haven’t confirmed the same benefits yet. Eating radish as part of a healthy diet is safe and nutritious, but it shouldn’t replace proven medical treatments for obesity or liver disease.
How much glucoraphenin do I need to see health benefits?
The mouse study used 1 mg per kilogram of body weight, but converting this to a human dose isn’t straightforward. No human studies have tested glucoraphenin doses yet, so we don’t know the effective or safe amount for people. Consult your doctor before taking supplements.
Does glucoraphenin work by changing gut bacteria?
Research suggests glucoraphenin helps restore healthy gut bacteria diversity and beneficial metabolites that Western diets damage. This improved gut health may contribute to reduced weight gain and liver protection, but the exact mechanisms in humans remain unclear.
What cruciferous vegetables contain glucoraphenin?
Glucoraphenin is the major glucosinolate in radish greens and sprouts, but other cruciferous vegetables like broccoli, cabbage, and Brussels sprouts contain similar beneficial compounds called glucosinolates that may have protective effects.
When will human studies test glucoraphenin for weight loss?
No human studies of glucoraphenin have been published yet. Researchers typically conduct animal studies first, then design human trials if results are promising. It may take several years before human research is available.
Want to Apply This Research?
- Track weekly servings of cruciferous vegetables (radish, broccoli, cabbage, Brussels sprouts) and monitor changes in energy levels, digestion comfort, and body weight over 8-12 weeks. Set a goal of 3-4 servings per week and log actual intake.
- Add one serving of radish greens, radish sprouts, or other cruciferous vegetables to your diet 3-4 times per week. Start with small amounts (a handful of greens in salads or cooked as a side dish) and gradually increase. Track how you feel and any changes in digestion or energy.
- Use the app to log cruciferous vegetable intake weekly, track body weight monthly, and note digestive health and energy levels. After 8-12 weeks, review trends to see if increased vegetable intake correlates with improvements in how you feel. Share results with your healthcare provider.
This article summarizes preliminary animal research and should not be considered medical advice. Glucoraphenin has not been tested in humans, and its safety and effectiveness in people are unknown. Do not use glucoraphenin supplements or radish products as a replacement for medical treatment of obesity, fatty liver disease, or any other health condition. If you have concerns about your weight, liver health, or metabolic function, consult with a qualified healthcare provider. Always speak with your doctor before starting new supplements or making significant dietary changes, especially if you take medications or have existing health conditions.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.